Cite
HARVARD Citation
Umino, K. et al. (2019). Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 60 (8), pp. 1926-1933. [Online].